Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-02-26 | New | $100,000 | $100,000 | Debt Only | 06b | SEC link |
| 2022-10-17 | Amended | $1,000,000 | $0 | Debt Only | 06b | SEC link |
| 2022-10-17 | Amended | $1,000,000 | $0 | Debt Only | 06b | SEC link |
| 2022-10-14 | New | $1,000,000 | $1,000,000 | Debt Only | 06b | SEC link |
| 2022-10-11 | New | $4,020,000 | $4,020,000 | Equity Only | 06b | SEC link |
| 2022-08-22 | New | $9,979,274 | $9,979,274 | Equity Only | 06b | SEC link |
| 2022-08-22 | New | $8,320,515 | $8,320,515 | Equity Only | 06b | SEC link |
| 2017-11-06 | New | $325,000 | $325,000 | Debt Only | 06b | SEC link |
| 2017-05-23 | New | $770,000 | $770,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| J. Anthony Antonelli | Director |
| James Burgess | Executive |
| Jeff Hone | Director, Executive |
| D. Brent Israelsen | Director, Executive |
| Morris Linton | Executive |
| Kent Misener | Director |
| Robert P.K. Mooney | Director, Executive |
| Barry Mower | Director |
| Jeffrey Nelson | Director |
| Kim O'neill | Director, Executive |
| Scott Peterson | Director |
| D. Todd Schulthess | Director, Executive, Promoter |
| Steven Tanner | Director |